# Biocomma

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/biocomma

- Industry: Medical Devices & Equipment
- Headquarters: Shenzhen, China
- Website: www.biocomma.cn
- Total disclosed funding: $16M
- Latest round: Series A (Nov 8, 2021)
- Investors on record: 4

## About

Based in Shenzhen, China, and established in 2006, Biocomma Limited is a manufacturer of filtration, sample preparation and life science products. The company owns filtration facility, two cleanrooms and one research & development center, supplying more than 1500 products. It's products used in many areas such as gene detection, new drug discover, food safety, environmental protection, and etc. It has served over 4,000 customers and provided original equipment manufacture ( OEM ) and custom services for dozens brands around the world.

The company provides filtration products, and life science products. The filtration products focusing on small sintered PE filters, used in chemical analysis and life science, including pipette tip filters, self-sealing filters, and hydrophilic and hydrophobic PE frits. The sample preparation products include sold phase extraction, solid supported liquid extraction and liquid extraction and dispersive solid phase extraction. The life science products include CPG frits, nucleic acid extraction purification kits, desalting purification cartridges and etc.

The company plans to expand sample preparation products line and increase the company's barriers.

## Funding rounds

- Series A, Nov 8, 2021, $16M — SB China Venture Capital, Shenzhen HTI, YuanBio Venture, Shenzhen Capital Real Estate Fund

## Investors

- SB China Venture Capital (https://capitalatlas.ai/funds/sb-china-venture-capital) — Series A
- Shenzhen HTI (https://capitalatlas.ai/funds/shenzhen-hti) — Series A
- YuanBio Venture (https://capitalatlas.ai/funds/yuanbio-venture) — Series A
- Shenzhen Capital Real Estate Fund (https://capitalatlas.ai/funds/shenzhen-capital-real-estate-fund) — Series A